Stock Rich List
#7717 on the rich list of 14,644 insiders

Braden M Leonard

10% owner at Enliven Therapeutics; 10% owner at Aclaris Therapeutics; 10% owner at AN2 Therapeutics. Based in Zionsville, Indiana.

$11.9M
in disclosed stock, +$320K (+2.77%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
7717th of 14,644
Companies held
5
Largest holding
ELVN, 89.9% of total
Latest SEC filing
Oct 2, 2026
Listed but not counted
$171M

What the $11.9M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Enliven Therapeutics ELVN
Common Stock
Directly230,000$46.41$10.7M89.9%Form 4/A, Jan 3, 2023
Disc Medicine IRON
Common Stock
Directly8,250
split-adjusted
$76.11$628K5.3%Form 4, Oct 26, 2022
OnKure Therapeutics OKUR
Common Stock
Directly102,076$2.76$282K2.4%Form 4, Oct 7, 2024
Retractable Technologies RVP
Common Stock
Directly387,500$0.60$232K2.0%Form 4, Dec 29, 2022
Tectonic Therapeutic TECX
Common Stock
Directly2,778
split-adjusted
$21.04$58K0.5%Form 4, Jun 20, 2024

Share counts are the amounts Braden M Leonard reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Braden M Leonard's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Enliven Therapeutics ELVN
Common Stock
Holding of BML Investment Partners, L.P.
Held by a company or fund the insider manages
1,767,774$46.41$82.0M—Form 4, Jan 4, 2023
Aclaris Therapeutics ACRS
Common Stock
Holdings of BML Investment Partners, L.P.
Held by a company or fund the insider manages
13,950,000$3.50$48.8M—Form 4, Apr 23, 2026
AN2 Therapeutics ANTX
Common Stock
Holding of BML Investment Partners, L.P.
Held by a company or fund the insider manages
3,217,432$5.22$16.8M—Form 4, May 30, 2025
Disc Medicine IRON
Common Stock
Holding of BML Investment Partners, L.P.
Held by a company or fund the insider manages
166,667
split-adjusted
$76.11$12.7M—Form 4, Oct 26, 2022
Outset Medical OM
Common Stock
Holdings of BML Investment Partners, L.P.
Held by a company or fund the insider manages
2,764,610$2.91$8.0M—Form 4, Oct 2, 2026
OnKure Therapeutics OKUR
Common Stock
Holding of BML Investment Partners, L.P.
Held by a company or fund the insider manages
345,740
split-adjusted
$2.76$954K—Form 4, Sep 25, 2024
OnKure Therapeutics OKUR
Common Stock
Holdings of BML Investment Partners, L.P.
Held by a company or fund the insider manages
345,739$2.76$954K—Form 4, Oct 7, 2024
Tectonic Therapeutic TECX
Common Stock
Holding of BML Investment Partners, L.P,
Held by a company or fund the insider manages
33,363
split-adjusted
$21.04$702K—Form 4, Jun 20, 2024
Retractable Technologies RVP
Common Stock
Holding of BML Investment Partners, L.P.
Held by a company or fund the insider manages
688,575$0.60$412K—Form 4, Dec 29, 2022

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Oct 2, 2026BoughtOM16,575$3.88$64KView
Oct 1, 2026BoughtOM228,334$3.53$806KView
Apr 23, 2026SoldACRS300,000$4.53$1.4MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
7714David Boulette
Chief Executive Officer, Eva Live. Las Vegas, NV
$11.9M+$1.2M (+11.13%)
7715Neena M. Patil
EVP & Chief Legal Officer, Jazz Pharmaceuticals
$11.9M−$549K (−4.42%)
7716Michael S. Brown
Director, Regeneron Pharmaceuticals. Tarrytown, NY
$11.9M−$285K (−2.35%)
7717Braden M Leonard
10% owner, Enliven Therapeutics. Zionsville, IN
$11.9M+$320K (+2.77%)
7718Mayur Kapani
Chief Technology Officer, Intercontinental Exchange. Atlanta, GA
$11.9M−$65K (−0.54%)
7719Mark J. Silk
Director, SIFCO Industries. Cleveland, OH
$11.9M+$48K (+0.41%)
7720Daniel M. Sessa
EVP, Chief HR Officer, Lennox International. Richardson, TX
$11.9M+$1K (+0.01%)

Other Enliven Therapeutics insiders

All ELVN insiders

Questions

How much stock does Braden M Leonard own?

Braden M Leonard holds $11,874,494 in listed stock based on SEC filings and current prices, mostly Enliven Therapeutics (ELVN). That ranks 7717th on the Stock Rich List.

Is this Braden M Leonard's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Braden M Leonard last buy or sell stock?

The most recent open-market trade on file is a purchase of 16,575 OM shares on Oct 2, 2026 at $3.88.